Guardant Health
GH
#1787
Rank
C$15.41 B
Marketcap
C$117.54
Share price
-3.96%
Change (1 day)
81.96%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -C$0.58 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$0.98 Billion. , an increase over its 2024 earnings that were of -C$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.59 Billion-4.03%
2024 -C$0.61 Billion-9.12%
2023 -C$0.67 Billion-26.73%
2022 -C$0.91 Billion69.96%
2021 -C$0.54 Billion56.35%
2020 -C$0.35 Billion252.69%
2019 -C$96.86 Million-17.22%
2018 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-C$0.86 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-C$0.38 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA